J
Joseph G. McCormack
Researcher at University of Queensland
Publications - 112
Citations - 5763
Joseph G. McCormack is an academic researcher from University of Queensland. The author has contributed to research in topics: Cystic fibrosis & Klebsiella pneumoniae. The author has an hindex of 30, co-authored 112 publications receiving 5477 citations. Previous affiliations of Joseph G. McCormack include Mater Misericordiae Hospital & Mater Health Services.
Papers
More filters
Journal ArticleDOI
International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum β-Lactamase Production in Nosocomial Infections
David L. Paterson,Wen Chien Ko,Anne von Gottberg,Sunlta Mohapatra,Jose Maria Casellas,Herman Goossens,Lutfiye Mulazimoglu,Gordon M. Trenholme,Kelth P. Klugman,Robert A. Bonomo,Louis B. Rice,Marilyn M. Wagener,Joseph G. McCormack,Victor L. Yu +13 more
TL;DR: ESBL-producing gram-negative bacilli were found to truly be multiresistant pathogens and were resistant to all -lactam antibiotics, most aminoglycosides, trimethoprimsulfamethoxazole, and sometimes the fluoroquinolones.
Journal ArticleDOI
Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology Laboratory
David L. Paterson,David L. Paterson,Wen Chien Ko,Anne von Gottberg,Jose Maria Casellas,Lutfiye Mulazimoglu,Keith P. Klugman,Robert A. Bonomo,Louis B. Rice,Joseph G. McCormack,Victor L. Yu +10 more
TL;DR: It is clinically important to detect ESBL production by klebsiellae or E. coli even when cephalosporin MICs are in the susceptible range (≤ 8 μg/ml) and to report ESBL-producing organisms as resistant to aztreonam and all cep Halosporins (with the exception of cephamycins).
Journal ArticleDOI
Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum β-Lactamases
David L. Paterson,David L. Paterson,Wen Chien Ko,Anne von Gottberg,Sunita Mohapatra,Jose Maria Casellas,Herman Goossens,Lutfiye Mulazimoglu,Gordon M. Trenholme,Keith P. Klugman,Robert A. Bonomo,Louis B. Rice,Marilyn M. Wagener,Joseph G. McCormack,Victor L. Yu +14 more
TL;DR: Multivariate analysis including other predictors of mortality showed that use of a carbapenem during the 5-day period after onset of bacteremia due to an ESBL-producing organism was independently associated with lower mortality.
Journal ArticleDOI
Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns.
Wen Chien Ko,David L. Paterson,Anthanasia J. Sagnimeni,Dennis S. Hansen,Anne von Gottberg,Sunita Mohapatra,Jose Maria Casellas,Herman Goossens,Lutfiye Mulazimoglu,Gordon M. Trenholme,Keith P. Klugman,Joseph G. McCormack,Victor L. Yu +12 more
TL;DR: A distinctive form of K. pneumoniae infection, often causing liver abscess, was identified, almost exclusively in Taiwan.
Journal ArticleDOI
Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: A randomised trial
TL;DR: AZM in adults with CF significantly improved QOL, reduced CRP levels and the number of respiratory exacerbations, and reduced the rate of decline in lung function, suggesting long term AZM may have a significant impact on morbidity and mortality in patients with CF.